Predictive value for future arrhythmic events of fractal dimension, a measure of time clustering of ventricular premature complexes, after myocardial infarction

被引:15
作者
Anderson, JL
Karagounis, LA
Stein, KM
Moreno, FL
Ledingham, R
Hallstrom, A
机构
[1] CORNELL UNIV, MED CTR, NEW YORK, NY 10021 USA
[2] CARDIAC ARRHYTHMIA SUPPRESS TRIAL COORDINATING CT, SEATTLE, WA USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0735-1097(97)00108-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. Our objective was to test fractal dimension (D), a measure of clustering of ventricular premature complexes (VPCs), on entry Holter recording as a predictor of future arrhythmic death and other cause mortality in postinfarction patients in the Cardiac Arrhythmic Suppression Trial (CAST). Background. Nonlinear dynamic methods of signal processing are being applied in medicine to provide new insights into apparently ''chaotic'' biologic events, including cardiac arrhythmias, One such application is the derivation of a fractal D to describe the clustering of VPCs in time. Methods. Baseline Holter recordings were analyzed in blinded manner for 484 patients: 237 died or had a resuscitated cardiac arrest during follow-up, and 247 matched patients had no events, Fractal D, measured in four ways, was assessed as a predictor using Cox regression. Results. One measure of D (high resolution D) was a significant univariate (relative hazard ratio 0.79 per SD change, p = 0.011) and multivariate (hazard ratio 0.75, p = 0.046) predictor of arrhythmic death but not other death (univariate p = 0.95, relative hazard 0.95, p = 0.66), Fractal D was greater (VPCs less clustered) in those patients free of arrhythmic events, On subgroup analysis, the predictive value of D resided in the randomized patient group (i.e., those who showed VPC suppression during initial antiarrhythmic drug titration and were randomized to blinded therapy with active drug or placebo) (multivariate hazard ratio 0.57, p = 0.001). Conclusions. A high resolution fractal D was predictive of arrhythmic (but not nonarrhythmic) death in a large postinfarction cohort, Further study of this new signal processing approach to ambulatory electrocardiographic recording will be of interest. (C) 1997 by the American College of Cardiology.
引用
收藏
页码:226 / 232
页数:7
相关论文
共 33 条
[1]  
ANDERSON J L, 1992, Journal of the American College of Cardiology, V19, p265A
[2]  
[Anonymous], 1989, NEW ENGL J MED, V321, P406
[3]   THE RELATIONSHIPS AMONG VENTRICULAR ARRHYTHMIAS, LEFT-VENTRICULAR DYSFUNCTION, AND MORTALITY IN THE 2 YEARS AFTER MYOCARDIAL-INFARCTION [J].
BIGGER, JT ;
FLEISS, JL ;
KLEIGER, R ;
MILLER, JP ;
ROLNITZKY, LM .
CIRCULATION, 1984, 69 (02) :250-258
[4]   THE ABILITY OF SEVERAL SHORT-TERM MEASURES OF RR VARIABILITY TO PREDICT MORTALITY AFTER MYOCARDIAL-INFARCTION [J].
BIGGER, JT ;
FLEISS, JL ;
ROLNITZKY, LM ;
STEINMAN, RC .
CIRCULATION, 1993, 88 (03) :927-934
[5]  
COX DR, 1972, J R STAT SOC B, V34, P187
[6]   FASCINATING RHYTHM - A PRIMER ON CHAOS THEORY AND ITS APPLICATION TO CARDIOLOGY [J].
DENTON, TA ;
DIAMOND, GA ;
HELFANT, RH ;
KHAN, S ;
KARAGUEUZIAN, H .
AMERICAN HEART JOURNAL, 1990, 120 (06) :1419-1440
[7]   MORTALITY AND MORBIDITY IN PATIENTS RECEIVING ENCAINIDE, FLECAINIDE, OR PLACEBO - THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL [J].
ECHT, DS ;
LIEBSON, PR ;
MITCHELL, LB ;
PETERS, RW ;
OBIASMANNO, D ;
BARKER, AH ;
ARENSBERG, D ;
BAKER, A ;
FRIEDMAN, L ;
GREENE, HL ;
HUTHER, ML ;
RICHARDSON, DW .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) :781-788
[8]   DEFINITION OF THE BEST PREDICTION CRITERIA OF THE TIME-DOMAIN SIGNAL-AVERAGED ELECTROCARDIOGRAM FOR SERIOUS ARRHYTHMIC EVENTS IN THE POSTINFARCTION PERIOD [J].
ELSHERIF, N ;
DENES, P ;
KATZ, R ;
CAPONE, R ;
MITCHELL, LB ;
CARLSON, M ;
REYNOLDSHAERTLE, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (04) :908-914
[9]   MORTALITY FOLLOWING VENTRICULAR ARRHYTHMIA SUPPRESSION BY ENCAINIDE, FLECAINIDE, AND MORICIZINE AFTER MYOCARDIAL-INFARCTION - THE ORIGINAL DESIGN CONCEPT OF THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL (CAST) [J].
EPSTEIN, AE ;
HALLSTROM, AP ;
ROGERS, WJ ;
LIEBSON, PR ;
SEALS, AA ;
ANDERSON, JL ;
COHEN, JD ;
CAPONE, RJ ;
WYSE, DG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (20) :2451-2455
[10]   EVENTS IN THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL (CAST) - MORTALITY IN THE ENTIRE POPULATION ENROLLED [J].
EPSTEIN, AE ;
BIGGER, JT ;
WYSE, DG ;
ROMHILT, DW ;
REYNOLDSHAERTLE, RA ;
HALLSTROM, AP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (01) :14-19